+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Activin-A Market by Application (Bone Regeneration, Drug Discovery, Tissue Engineering), Product Type (Analogues, Biosimilar Activin-A, Recombinant Activin-A), Formulation, End User, Route Of Administration, Distribution Channel - Global Forecast 2025-2030- Product Image
Activin-A Market by Application (Bone Regeneration, Drug Discovery, Tissue Engineering), Product Type (Analogues, Biosimilar Activin-A, Recombinant Activin-A), Formulation, End User, Route Of Administration, Distribution Channel - Global Forecast 2025-2030- Product Image
Sale

Activin-A Market by Application (Bone Regeneration, Drug Discovery, Tissue Engineering), Product Type (Analogues, Biosimilar Activin-A, Recombinant Activin-A), Formulation, End User, Route Of Administration, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 188 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5305483
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Activin-A market is entering a period of transformative growth, fueled by its expanding applications in biotechnology and regenerative medicine. This momentum is shaped by ongoing innovation, shifting regulatory landscapes, and evolving supply chain strategies that demand close attention from senior decision-makers.

Market Snapshot: Activin-A Market Size and Growth Trajectory

The Activin-A Market grew from USD 287.73 million in 2024 to USD 316.71 million in 2025. It is expected to continue growing at a CAGR of 9.61%, reaching USD 499.04 million by 2030.

Scope & Segmentation

This comprehensive analysis maps the breadth and depth of the Activin-A market across applications, product types, formulations, end users, administration routes, distribution channels, geographic regions, and competitive dynamics.

  • Applications: Bone regeneration, drug discovery (including high throughput screening and target validation), tissue engineering (for cardiac, neural, and skin constructs), and wound healing (burn restoration, diabetic foot ulcer, pressure ulcer management).
  • Product Variants: Analogues with tailored modifications, biosimilar Activin-A alternatives, and recombinant preparations optimized through engineered expression systems.
  • Formulations: Liquid solutions for rapid use and lyophilized powder formats ensuring flexible storage and long-term stability.
  • End Users: Academic research institutes, contract research organizations, hospitals and clinics, and pharmaceutical biotech companies.
  • Administration Routes: Injectable as the principal method, alongside expanding investigational topical applications.
  • Distribution Channels: Direct tender sales to institutions, regional and global distributors and retailers, and online sales platforms to widen accessibility.
  • Geographic Regions: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East and Africa (with key markets such as United Kingdom, Germany, France, as well as Middle Eastern and African nations), and Asia-Pacific (covering China, India, Japan, Australia, South Korea, and other regional markets).
  • Leading Companies: Thermo Fisher Scientific Inc., Merck KGaA, Bio-Techne Corporation, Abcam plc, BioLegend, Inc., GenScript Biotech Corporation, Sino Biological Inc., RayBiotech Life Inc., Proteintech Group, Inc., Enzo Life Sciences, Inc.

Key Takeaways for Senior Decision-Makers

  • Activin-A underpins strategic advances in regenerative medicine, with significant potential in tissue repair and therapeutic innovation across multiple domains.
  • Breakthroughs in formulation—particularly in lyophilized powders and precision liquid solutions—are making stable, scalable manufacturing and delivery a core competitive advantage.
  • Regulatory pathways for biosimilar and recombinant products are evolving, streamlining entry to market while prioritizing safety and efficacy.
  • Regional alliances and public-private partnerships support early-stage innovation and facilitate de-risking, especially as organizations adapt to new trade and funding environments.
  • Digital supply chain tools and predictive analytics are enhancing transparency, inventory management, and alignment with shifting global demand patterns.

Tariff Impact on the Activin-A Market

Newly imposed tariffs on critical biomanufacturing inputs in the United States have introduced cost pressures for contract research organizations and pharmaceutical developers. Sourcing of recombinant components now faces elevated duties, driving stakeholders to reassess procurement, consider nearshoring, and pursue domestic alternatives. These changes ripple across pricing, collaboration, and grant allocations, raising the importance of supply chain diversification and flexible contracts. Globally, reciprocal measures and shifting trade agreements may further influence cross-border collaborations and export strategies.

Methodology & Data Sources

The research employs a robust blend of secondary data review—covering scientific literature, industry papers, and regulatory updates—and targeted primary interviews with key industry opinion leaders. Quantitative figures are triangulated with publicly available registries and manufacturing data, ensuring insights are validated and current.

Why This Report Matters

  • Enables pharmaceutical and research stakeholders to anticipate Activin-A market shifts and build resilient, responsive supply chain strategies.
  • Identifies actionable opportunities for collaboration, innovation, and regulatory engagement in a rapidly evolving therapeutic landscape.
  • Offers an integrated framework to refine strategic planning, optimize resource allocations, and translate laboratory advances into scalable clinical solutions.

Conclusion

This report equips leaders with a focused, actionable roadmap for capturing emerging Activin-A opportunities. By aligning strategy with regulatory, technological, and market trends, organizations can drive innovation and clinical impact in the years ahead.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Emerging adoption of Activin-A inhibitors in preclinical and clinical fibrotic disease pipeline
5.2. Strategic partnerships between biotech firms and academic institutions for Activin-A research expansion
5.3. Advances in diagnostic assays measuring Activin-A levels for early disease detection and prognosis
5.4. Impact of evolving regulatory guidance on approval timelines for Activin-A targeted biologics
5.5. Growth of personalized medicine approaches leveraging Activin-A modulation in oncological therapies
5.6. Role of high-throughput screening technologies in accelerating Activin-A ligand discovery and optimization
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Activin-A Market, by Application
8.1. Introduction
8.2. Bone Regeneration
8.3. Drug Discovery
8.3.1. High Throughput Screening
8.3.2. Target Validation
8.4. Tissue Engineering
8.4.1. Cardiac Tissue Engineering
8.4.2. Neural Tissue Engineering
8.4.3. Skin Tissue Engineering
8.5. Wound Healing
8.5.1. Burn Restoration
8.5.2. Diabetic Foot Ulcer
8.5.3. Pressure Ulcer
9. Activin-A Market, by Product Type
9.1. Introduction
9.2. Analogues
9.3. Biosimilar Activin-A
9.4. Recombinant Activin-A
10. Activin-A Market, by Formulation
10.1. Introduction
10.2. Liquid Solution
10.3. Lyophilized Powder
11. Activin-A Market, by End User
11.1. Introduction
11.2. Academic Research Institutes
11.3. Contract Research Organizations
11.4. Hospitals And Clinics
11.5. Pharmaceutical Biotech Companies
12. Activin-A Market, by Route Of Administration
12.1. Introduction
12.2. Injectable
12.3. Topical
13. Activin-A Market, by Distribution Channel
13.1. Introduction
13.2. Direct Tender Sales
13.3. Distributors And Retailers
13.4. Online Sales
14. Americas Activin-A Market
14.1. Introduction
14.2. United States
14.3. Brazil
14.4. Argentina
14.5. Mexico
14.6. Canada
15. Europe, Middle East & Africa Activin-A Market
15.1. Introduction
15.2. Denmark
15.3. Poland
15.4. Russia
15.5. Sweden
15.6. Qatar
15.7. Finland
15.8. Turkey
15.9. South Africa
15.10. Saudi Arabia
15.11. Spain
15.12. Egypt
15.13. Germany
15.14. Switzerland
15.15. Norway
15.16. France
15.17. Italy
15.18. United Kingdom
15.19. United Arab Emirates
15.20. Israel
15.21. Netherlands
15.22. Nigeria
16. Asia-Pacific Activin-A Market
16.1. Introduction
16.2. Japan
16.3. Thailand
16.4. China
16.5. Singapore
16.6. India
16.7. Malaysia
16.8. Indonesia
16.9. South Korea
16.10. Vietnam
16.11. Philippines
16.12. Taiwan
16.13. Australia
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Thermo Fisher Scientific Inc.
17.3.2. Merck KGaA
17.3.3. Bio-Techne Corporation
17.3.4. Abcam plc
17.3.5. BioLegend, Inc.
17.3.6. GenScript Biotech Corporation
17.3.7. Sino Biological Inc.
17.3.8. RayBiotech Life Inc.
17.3.9. Proteintech Group, Inc.
17.3.10. Enzo Life Sciences, Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. ACTIVIN-A MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ACTIVIN-A MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ACTIVIN-A MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ACTIVIN-A MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ACTIVIN-A MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ACTIVIN-A MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ACTIVIN-A MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ACTIVIN-A MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ACTIVIN-A MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ACTIVIN-A MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS ACTIVIN-A MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS ACTIVIN-A MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES ACTIVIN-A MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES ACTIVIN-A MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ACTIVIN-A MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ACTIVIN-A MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC ACTIVIN-A MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC ACTIVIN-A MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ACTIVIN-A MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. ACTIVIN-A MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. ACTIVIN-A MARKET: RESEARCHAI
FIGURE 28. ACTIVIN-A MARKET: RESEARCHSTATISTICS
FIGURE 29. ACTIVIN-A MARKET: RESEARCHCONTACTS
FIGURE 30. ACTIVIN-A MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ACTIVIN-A MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ACTIVIN-A MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ACTIVIN-A MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ACTIVIN-A MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ACTIVIN-A MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ACTIVIN-A MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ACTIVIN-A MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ACTIVIN-A MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ACTIVIN-A MARKET SIZE, BY BONE REGENERATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ACTIVIN-A MARKET SIZE, BY BONE REGENERATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ACTIVIN-A MARKET SIZE, BY HIGH THROUGHPUT SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ACTIVIN-A MARKET SIZE, BY HIGH THROUGHPUT SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ACTIVIN-A MARKET SIZE, BY TARGET VALIDATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ACTIVIN-A MARKET SIZE, BY TARGET VALIDATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ACTIVIN-A MARKET SIZE, BY CARDIAC TISSUE ENGINEERING, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ACTIVIN-A MARKET SIZE, BY CARDIAC TISSUE ENGINEERING, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ACTIVIN-A MARKET SIZE, BY NEURAL TISSUE ENGINEERING, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ACTIVIN-A MARKET SIZE, BY NEURAL TISSUE ENGINEERING, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ACTIVIN-A MARKET SIZE, BY SKIN TISSUE ENGINEERING, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ACTIVIN-A MARKET SIZE, BY SKIN TISSUE ENGINEERING, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ACTIVIN-A MARKET SIZE, BY WOUND HEALING, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ACTIVIN-A MARKET SIZE, BY WOUND HEALING, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ACTIVIN-A MARKET SIZE, BY BURN RESTORATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ACTIVIN-A MARKET SIZE, BY BURN RESTORATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ACTIVIN-A MARKET SIZE, BY DIABETIC FOOT ULCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ACTIVIN-A MARKET SIZE, BY DIABETIC FOOT ULCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ACTIVIN-A MARKET SIZE, BY PRESSURE ULCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ACTIVIN-A MARKET SIZE, BY PRESSURE ULCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ACTIVIN-A MARKET SIZE, BY ANALOGUES, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ACTIVIN-A MARKET SIZE, BY ANALOGUES, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ACTIVIN-A MARKET SIZE, BY BIOSIMILAR ACTIVIN-A, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ACTIVIN-A MARKET SIZE, BY BIOSIMILAR ACTIVIN-A, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ACTIVIN-A MARKET SIZE, BY RECOMBINANT ACTIVIN-A, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ACTIVIN-A MARKET SIZE, BY RECOMBINANT ACTIVIN-A, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ACTIVIN-A MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ACTIVIN-A MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ACTIVIN-A MARKET SIZE, BY LIQUID SOLUTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ACTIVIN-A MARKET SIZE, BY LIQUID SOLUTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ACTIVIN-A MARKET SIZE, BY LYOPHILIZED POWDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ACTIVIN-A MARKET SIZE, BY LYOPHILIZED POWDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ACTIVIN-A MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ACTIVIN-A MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ACTIVIN-A MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ACTIVIN-A MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ACTIVIN-A MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ACTIVIN-A MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ACTIVIN-A MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ACTIVIN-A MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ACTIVIN-A MARKET SIZE, BY PHARMACEUTICAL BIOTECH COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ACTIVIN-A MARKET SIZE, BY PHARMACEUTICAL BIOTECH COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL ACTIVIN-A MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL ACTIVIN-A MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL ACTIVIN-A MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL ACTIVIN-A MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL ACTIVIN-A MARKET SIZE, BY DIRECT TENDER SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL ACTIVIN-A MARKET SIZE, BY DIRECT TENDER SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL ACTIVIN-A MARKET SIZE, BY DISTRIBUTORS AND RETAILERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL ACTIVIN-A MARKET SIZE, BY DISTRIBUTORS AND RETAILERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL ACTIVIN-A MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL ACTIVIN-A MARKET SIZE, BY ONLINE SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS ACTIVIN-A MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS ACTIVIN-A MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS ACTIVIN-A MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS ACTIVIN-A MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS ACTIVIN-A MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS ACTIVIN-A MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS ACTIVIN-A MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES ACTIVIN-A MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES ACTIVIN-A MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES ACTIVIN-A MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES ACTIVIN-A MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES ACTIVIN-A MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES ACTIVIN-A MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES ACTIVIN-A MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 119. BRAZIL ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 120. BRAZIL ACTIVIN-A MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 121. BRAZIL ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 122. BRAZIL ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 123. BRAZIL ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 124. BRAZIL ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 125. BRAZIL ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 126. BRAZIL ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 127. BRAZIL ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 128. BRAZIL ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 129. BRAZIL ACTIVIN-A MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 130. BRAZIL ACTIVIN-A MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 131. BRAZIL ACTIVIN-A MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 132. BRAZIL ACTIVIN-A MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 137. ARGENTINA ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 138. ARGENTINA ACTIVIN-A MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 139. ARGENTINA ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 140. ARGENTINA ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 141. ARGENTINA ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 142. ARGENTINA ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 143. ARGENTINA ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 144. ARGENTINA ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 145. ARGENTINA ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 146. ARGENTINA ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 147. ARGENTINA ACTIVIN-A MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 148. ARGENTINA ACTIVIN-A MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 149. ARGENTINA ACTIVIN-A MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 150. ARGENTINA ACTIVIN-A MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 155. MEXICO ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 156. MEXICO ACTIVIN-A MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 157. MEXICO ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 158. MEXICO ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 159. MEXICO ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 160. MEXICO ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 161. MEXICO ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 162. MEXICO ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 163. MEXICO ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 164. MEXICO ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 165. MEXICO ACTIVIN-A MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 166. MEXICO ACTIVIN-A MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 167. MEXICO ACTIVIN-A MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. MEXICO ACTIVIN-A MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. MEXICO ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 170. MEXICO ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 171. MEXICO ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 172. MEXICO ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 173. CANADA ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 174. CANADA ACTIVIN-A MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 175. CANADA ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 176. CANADA ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 177. CANADA ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 178. CANADA ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 179. CANADA ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 180. CANADA ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 181. CANADA ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 182. CANADA ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 183. CANADA ACTIVIN-A MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 184. CANADA ACTIVIN-A MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 185. CANADA ACTIVIN-A MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 186. CANADA ACTIVIN-A MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 187. CANADA ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 188. CANADA ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 189. CANADA ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 190. CANADA ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA ACTIVIN-A MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA ACTIVIN-A MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA ACTIVIN-A MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA ACTIVIN-A MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA ACTIVIN-A MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA ACTIVIN-A MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA ACTIVIN-A MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 211. DENMARK ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 212. DENMARK ACTIVIN-A MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 213. DENMARK ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 214. DENMARK ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 215. DENMARK ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 216. DENMARK ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 217. DENMARK ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 218. DENMARK ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 219. DENMARK ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 220. DENMARK ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 221. DENMARK ACTIVIN-A MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 222. DENMARK ACTIVIN-A MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 223. DENMARK ACTIVIN-A MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 224. DENMARK ACTIVIN-A MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 225. DENMARK ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 226. DENMARK ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 227. DENMARK ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 228. DENMARK ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 229. POLAND ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 230. POLAND ACTIVIN-A MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 231. POLAND ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 232. POLAND ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 233. POLAND ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 234. POLAND ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 235. POLAND ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 236. POLAND ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 237. POLAND ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 238. POLAND ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 239. POLAND ACTIVIN-A MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 240. POLAND ACTIVIN-A MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 241. POLAND ACTIVIN-A MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. POLAND ACTIVIN-A MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. POLAND ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 244. POLAND ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 245. POLAND ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 246. POLAND ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 247. RUSSIA ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 248. RUSSIA ACTIVIN-A MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 249. RUSSIA ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 250. RUSSIA ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 251. RUSSIA ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 252. RUSSIA ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 253. RUSSIA ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 254. RUSSIA ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 255. RUSSIA ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 256. RUSSIA ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 257. RUSSIA ACTIVIN-A MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 258. RUSSIA ACTIVIN-A MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 259. RUSSIA ACTIVIN-A MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 260. RUSSIA ACTIVIN-A MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 261. RUSSIA ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 262. RUSSIA ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 263. RUSSIA ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 264. RUSSIA ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 265. SWEDEN ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 266. SWEDEN ACTIVIN-A MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 267. SWEDEN ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 268. SWEDEN ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 269. SWEDEN ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 270. SWEDEN ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 271. SWEDEN ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 272. SWEDEN ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 273. SWEDEN ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 274. SWEDEN ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 275. SWEDEN ACTIVIN-A MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 276. SWEDEN ACTIVIN-A MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 277. SWEDEN ACTIVIN-A MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 278. SWEDEN ACTIVIN-A MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 279. SWEDEN ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 280. SWEDEN ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 281. SWEDEN ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 282. SWEDEN ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 283. QATAR ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 284. QATAR ACTIVIN-A MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 285. QATAR ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 286. QATAR ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 287. QATAR ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 288. QATAR ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 289. QATAR ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 290. QATAR ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 291. QATAR ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 292. QATAR ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 293. QATAR ACTIVIN-A MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 294. QATAR ACTIVIN-A MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 295. QATAR ACTIVIN-A MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 296. QATAR ACTIVIN-A MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 297. QATAR ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 298. QATAR ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 299. QATAR ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 300. QATAR ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 301. FINLAND ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 302. FINLAND ACTIVIN-A MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 303. FINLAND ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 304. FINLAND ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 305. FINLAND ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 306. FINLAND ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 307. FINLAND ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 308. FINLAND ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 309. FINLAND ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 310. FINLAND ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 311. FINLAND ACTIVIN-A MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 312. FINLAND ACTIVIN-A MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 313. FINLAND ACTIVIN-A MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 314. FINLAND ACTIVIN-A MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 315. FINLAND ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 316. FINLAND ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 317. FINLAND ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 318. FINLAND ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 319. TURKEY ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 320. TURKEY ACTIVIN-A MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 321. TURKEY ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 322. TURKEY ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 323. TURKEY ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 324. TURKEY ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 325. TURKEY ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 326. TURKEY ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 327. TURKEY ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 328. TURKEY ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 329. TURKEY ACTIVIN-A MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 330. TURKEY ACTIVIN-A MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 331. TURKEY ACTIVIN-A MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 332. TURKEY ACTIVIN-A MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 333. TURKEY ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 334. TURKEY ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 335. TURKEY ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 336. TURKEY ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 337. SOUTH AFRICA ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 338. SOUTH AFRICA ACTIVIN-A MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 339. SOUTH AFRICA ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 340. SOUTH AFRICA ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 341. SOUTH AFRICA ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 342. SOUTH AFRICA ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 343. SOUTH AFRICA ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 344. SOUTH AFRICA ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 345. SOUTH AFRICA ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 346. SOUTH AFRICA ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 347. SOUTH AFRICA ACTIVIN-A MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 348. SOUTH AFRICA ACTIVIN-A MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 349. SOUTH AFRICA ACTIVIN-A MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 350. SOUTH AFRICA ACTIVIN-A MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 351. SOUTH AFRICA ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 352. SOUTH AFRICA ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 353. SOUTH AFRICA ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 354. SOUTH AFRICA ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 355. SAUDI ARABIA ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 356. SAUDI ARABIA ACTIVIN-A MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 357. SAUDI ARABIA ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 358. SAUDI ARABIA ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 359. SAUDI ARABIA ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 360. SAUDI ARABIA ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 361. SAUDI ARABIA ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 362. SAUDI ARABIA ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 363. SAUDI ARABIA ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 364. SAUDI ARABIA ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 365. SAUDI ARABIA ACTIVIN-A MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 366. SAUDI ARABIA ACTIVIN-A MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 367. SAUDI ARABIA ACTIVIN-A MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 368. SAUDI ARABIA ACTIVIN-A MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 369. SAUDI ARABIA ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 370. SAUDI ARABIA ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 371. SAUDI ARABIA ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 372. SAU

Samples

Loading
LOADING...

Companies Mentioned

  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Bio-Techne Corporation
  • Abcam plc
  • BioLegend, Inc.
  • GenScript Biotech Corporation
  • Sino Biological Inc.
  • RayBiotech Life Inc.
  • Proteintech Group, Inc.
  • Enzo Life Sciences, Inc.

Table Information

Report AttributeDetails
No. of Pages188
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 316.71 Million
Forecasted Market Value ( USD ) by 2030 $ 499.04 Million
Compound Annual Growth Rate9.6%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Antimicrobial Peptides Market by Source (Natural, Synthetic), Structure (Alpha-helical, Beta-sheet, Loop), Mechanism of Action, Application - Global Forecast 2025-2030 - Product Image

Antimicrobial Peptides Market by Source (Natural, Synthetic), Structure (Alpha-helical, Beta-sheet, Loop), Mechanism of Action, Application - Global Forecast 2025-2030

  • Report
  • 199 Pages
  • Global
From
Centella Asiatica Market by Plant Part (Leaves, Roots & Stem), Product Variety (Herbal Blends, Single Herb), Product Form, Distribution Channel, End User, Application - Global Forecast 2025-2030 - Product Image

Centella Asiatica Market by Plant Part (Leaves, Roots & Stem), Product Variety (Herbal Blends, Single Herb), Product Form, Distribution Channel, End User, Application - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Antimicrobial Peptides - Global Strategic Business Report - Product Image

Antimicrobial Peptides - Global Strategic Business Report

  • Report
  • 471 Pages
  • Global
From
Nucleic Acid Methylation Market Size, Share & Trends Analysis Report by Product & Services (Kits & Reagents, Enzymes), Type (DNA Methylation, RNA Methylation), Technology, Application, End-Use, and Region with Growth Forecasts, 2025-2030 - Product Image

Nucleic Acid Methylation Market Size, Share & Trends Analysis Report by Product & Services (Kits & Reagents, Enzymes), Type (DNA Methylation, RNA Methylation), Technology, Application, End-Use, and Region with Growth Forecasts, 2025-2030

  • Report
  • 120 Pages
  • Global
From
Native Collagen - Global Strategic Business Report - Product Image

Native Collagen - Global Strategic Business Report

  • Report
  • 302 Pages
  • Global
From

About the Activin A Market

Activin A is a member of the transforming growth factor-beta (TGF-β) superfamily of proteins, and is a homodimeric glycoprotein hormone. It is involved in a wide range of biological processes, including cell growth, differentiation, apoptosis, and immune regulation. Activin A is produced by a variety of cell types, including fibroblasts, macrophages, and endothelial cells. It is also found in a variety of tissues, including the brain, heart, and reproductive organs. Activin A is used in a variety of research applications, including cell culture, drug discovery, and disease modeling. It is also used in the development of therapeutic agents for a range of diseases, including cancer, diabetes, and cardiovascular disease. The Activin A market is composed of a variety of companies that produce and supply Activin A for research and therapeutic applications. These companies include Abcam, Merck KGaA, R&D Systems, Sigma-Aldrich, and Thermo Fisher Scientific. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.